Effect of dehydroepiandrosterone on cell growth and mitochondrial function in TM-3 cells

General and Comparative Endocrinology

Volumn 177, Issue 1, 2012, Pages 177-186

  Shen, Xuehuai ^a   Liu, Lin ^a   Yin, Fujian ^a   Ma, Haitian ^a   Zou, Sixiang ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Cell growth; Cell viability; DHEA; Mitochondrial function; TM 3 cell

Indexed keywords

CYCLIN A; CYCLIN B; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PRASTERONE; SUCCINATE DEHYDROGENASE;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; LEYDIG CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84860505748     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2012.03.007     Document Type: Article

References (46)

1. Arlt W. Dehydroepiandrosterone and aging. Best Pract. Res. Clin. Endocrinol. Metab. 2004, 18:363-380.
2. Bellei M., Battelli D., Fornieri C., Mori G., Muscatello U., Lardy H., Bobyleva V. Changes in liver structure and function after short-term and long-term treatment of rats with dehydroepiandrosterone. J. Nutr. 1992, 122:967-976.
3. Bernas T., Dobrucki J. Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry 2002, 47:236-242.
4. Biaglow J.E., Ayene I.S., Koch C.J., Donahue J., Stamato T.D., Tuttle S.W. G6PD deficient cells and the bioreduction of disulfides: effects of DHEA, GSH depletion and phenylamine oxide. Biochem. Biophys. Res. Commun. 2000, 273:846-852.
5. Boccuzzi G., Di-Monaco M., Brignardello E., Leonardi L., Gatto V., Pizzini A., Gallo M. Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line. Anticancer Res. 1993, 13:2267-2272.
6. Charalampopoulos I., Tsatsanis C., Dermitzaki E., Alexaki V.I., Castanas E., Margioris A.N., Gravanis A. Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 2004, 101:8209-8214.
7. Chen H., Hardy M.P., Zirkin B.R. Age-related decreases in Leydig cell testosterone production is not restored by exposure to LH in vitro. Endocrinology 2002, 143:1637-1642.
8. Correa F., García N., García G., Chávez E. Dehydroepiandrosterone as an inducer of mitochondrial permeability transition. J. Steroid Biochem. Mol. Biol. 2003, 87:279-284.
9. Dashtaki R., Whorton A.R., Murphy T.M., Chitano P., Reed W., Kennedy T.P. Dehydroepiandrosterone and analogs inhibit DNA binding of AP-1 and airway smooth muscle proliferation. J. Pharmacol. Exp. Ther. 1998, 285:876-883.
10. Di Monaco M., Pizzini A., Gatto V., Leonardi L., Gallo M., Brignardello E., Boccuzzi G. Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells. Br. J. Cancer 1997, 75:589-592.
11. Genazzani A.D., Lanzoni C., Genazzani A.R. Might DHEA be considered a beneficial replacement therapy in the elderly. J. Drugs Aging 2007, 24:173-185.
12. Guerrero A., Pamplona R., Portero-Otín M., Barja G., López-Torres M. Effect of thyroid status on lipid composition and peroxidation in the mouse liver. Free Rad. Biol. Med. 1999, 26:73-80.
13. Han Y.H., Kim S.Z., Kim S.H., Park W.H. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH. Cancer Lett. 2008, 270:40-55.
14. Hayashi T., Esaki T., Muto E., Kano H., Asai Y., Thakur N.K., Sumi D., Jayachandran M., Iguchi A. Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide. Arterioscler. Thromb. Vasc. Biol. 2000, 20:782-792.
15. Hunt P.J., Gurnell E.M., Huppert F.A., Richards C., Prevost A.T., Wass J.A., Herbert J., Chatterjee V.K. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab. 2000, 85:4650-4656.
16. Ishizawa M., Ishizuka T., Kajita K., Miura A., Kanoh Y., Kimura M., Yasuda K. Dehydroepiandrosterone (DHEA) stimulates glucose uptake in rat adipocytes: activation of phospholipase D. Comp. Biochem. Physiol. Part B 2001, 130:359-364.
17. Jahn M.P., Jacob M.H., Gomes L.F., Duarte R., Araújo A.S., Belló-Klein A., Ribeiro M.F., Kucharski L.C. The effect of long-term DHEA treatment on glucose metabolism, hydrogen peroxide and thioredoxin levels in the skeletal muscle of diabetic rats. J. Steroid Biochem. Mol. Biol. 2010, 120:38-44.
18. Krug A.W., Langbein H., Ziegler C.G., Bornstein S.R., Eisenhofer G., Ehrhart-Bornstein M. Dehydroepiandrosterone-sulphate (DHEA-S) promotes neuroendocrine differentiation of chromaffin pheochromocytoma PC12 cells. Mol. Cell Endocrinol. 2009, 300:126-131.
19. Labrie F., Luu-The V., Labrie C., Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front. Neuroendocrinol. 2001, 22:185-212.
20. Lee T.C., Lai G.J., Kao S.L., Ho I.C., Wu C.W. Protection of a rat tracheal epithelial cell line from paraquat toxicity by inhibition of glucose-6-phosphate dehydrogenase. Biochem. Pharmacol. 1993, 45:1143-1147.
21. Luo L., Chen H., Zirkin B.R. Temporal relationships among testosterone production, steroidogenic acute regulatory protein (StAR), and P450 side-chain cleavage enzyme (P450scc) during Leydig cell aging. J. Androl. 2005, 26:25-31.
22. Maciel E.N., Vercesi A.E., Castilho R.F. Oxidative stress in Ca(2+)-induced membrane permeability transition in brain mitochondria. J. Neurochem. 2001, 79:1237-1245.
23. Mohan P.F., Cleary M.P. Short-term effects of dehydroepiandrosterone treatment in rat on mitochondrial respiration. J. Nutr. 1991, 121:240-250.
24. Morales A.J., Haubrich R.H., Hwang J.Y., Asakura H., Yen S.S. The effect of six months treatment with a 100mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age advanced men and women. Clin. Endocrinol. (Oxf.) 1998, 49:421-432.
25. Nakashima N., Haji M., Sakai Y., Ono Y., Umeda F., Nawata H. Effect of dehydroepiandrosterone on glucose uptake in cultured human fibroblasts. Metabolism 1995, 44:543-548.
26. Perrini S., Natalicchio A., Laviola L., Belsanti G., Montrone C., Cignarelli A., Minielli V., Grano M., De Pergola G., Giorgino R., Giorgino F. Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane. Diabetes 2004, 53:41-52.
27. Raïs B., Comin B., Puigjaner J., Brandes J.L., Creppy E., Saboureau D., Ennamany R., Lee W.N., Boros L.G., Cascante M. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS Lett. 1999, 456:113-118.
28. Rice S.P.L., Zhang L., Grennan-Jones F., Agarwal N., Lewis M.D., Rees D.A., Ludgate M. Dehydroepiandrosterone (DHEA) treatment in vitro inhibits adipogenesis in human omental but not subcutaneous adipose tissue. Mol. Cell. Endocrinol. 2010, 320:51-57.
29. Rutter J., Winge D.R., Schiffman J.D. Succinate dehydrogenase - assembly, regulation and role in human disease. Mitochondrion 2010, 10:393-401.
30. Safiulina D., Peet N., Seppet E., Zharkovsky A., Kaasik A. Dehydroepiandrosterone inhibits complex I of the mitochondrial respiratory chain and is neurotoxic in vitro and in vivo at high concentrations. Toxicol. Sci. 2006, 93:348-356.
31. Sato K., Iemitsu M., Aizawa K., Ajisaka R. Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E961-E968.
32. Schulz S., Nyce J.W. Inhibition of protein isoprenylation and p21ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitro. Cancer Res. 1991, 51:6563-6567.
33. Schulz S., Klann R.C., Schönfeld S., Nyce J.W. Mechanism of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: role of isoprenoid biosynthesis. Cancer Res. 1992, 52:1372-1376.
34. Schwartz A.G., Pashko L.L. Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity. Ageing Res. Rev. 2004, 3:171-187.
35. Sicard F., Ehrhart-Bornstein M., Corbeil D., Sperber S., Krug A.W., Ziegler C.G., Rettori V., McCann S.M., Bornstein S.R. Age-dependent regulation of chromaffin cell proliferation by growth factors, dehydroepiandrosterone (DHEA), and DHEA sulfate. Proc. Natl. Acad. Sci. USA 2007, 104:2007-2012.
36. Song L.J., Tang X., Kong Y.L., Ma H.T., Zou S.X. The expression of serum steroid sex hormones and steroidogenic enzymes following intraperitoneal administration of dehydroepiandrosterone (DHEA) in male rats. Steroids 2010, 75:213-218.
37. Suzuki M., Wright L.S., Marwah P., Lardy H.A., Svendsen C.N. Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc. Natl. Acad. Sci. USA 2004, 101:3202-3207.
38. Swierczynski J., Mayer D. Dehydroepiandrosterone-induced lipid peroxidation in rat liver mitochondria. J. Steroid Biochem. Mol. Biol. 1996, 58:599-603.
39. Tang X., Ma H.T., Huang G.Q., Miao J.F., Zou S.X. The effect of dehydroepiandrosterone on lipogenic gene mRNA expression in cultured primary chicken hepatocytes. Eur. J. Lipid Sci. Technol. 2009, 111:432-441.
40. Webb S.J., Geoghegan T.E., Prough R.A., Michael Miller K.K. The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab. Rev. 2006, 38:89-116.
41. Widstrom R.L., Dillon J.S. Is there a receptor for dehydroepiandrosterone or dehydroepiandrosterone sulfate. Semin. Reprod. Med. 2004, 22:289-298.
42. Wolkowitz O.M., Reus V.I., Roberts E., Manfredi F., Chan T., Raum W.J., Ormiston S., Johnson R., Canick J., Brizendine L., Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol. Psychiatry 1997, 41:311-318.
43. Yamashita R., Saito T., Satoh S., Aoki K., Kaburagi Y., Sekihara H. Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2. Endocr. J. 2005, 52:727-733.
44. Yang N.C., Jeng K.C., Ho W.M., Hu M.L. DHEA inhibits cell growth and induces apoptosis in BV-2 cells and the effects are inversely associated with glucose concentration in the medium. J. Steroid Biochem. Mol. Biol. 2000, 75:159-166.
45. Yang N.C., Jeng K.C., Ho W.M., Hu M.L. ATP depletion is an important factor in DHEA-induced growth inhibition and apoptosis in BV-2 cells. Life Sci. 2002, 70:1979-1988.
46. Zapata E., Ventura J.L., De la Cruz K., Rodriguez E., Damián P., Massó F., Montaño L.F., López-Marure R. Dehydroepiandrosterone inhibits the proliferation of umbilical vein endothelial cells by enhancing the expression of p53 and p21, restricting the phosphorylation of retinoblastoma protein and is androgen- and estrogen-receptor independent. FEBS J. 2005, 272:1343-1353.